Canada markets close in 5 hours 19 minutes

Satsuma Pharmaceuticals, Inc. (STSA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
23.52-0.48 (-2.00%)
As of 10:38AM EDT. Market open.
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-12-31
2018-12-31
2017-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
31,694
24,196
6,433
4,193
Selling General and Administrative
6,644
4,685
1,082
754
Total Operating Expenses
38,338
28,881
7,515
4,947
Operating Income or Loss
-38,338
-28,881
-7,515
-4,947
Interest Expense
464
482
90
15
Total Other Income/Expenses Net
-
-1
187
-240
Income Before Tax
-37,133
-28,175
-7,346
-5,172
Income from Continuing Operations
-37,133
-28,175
-7,346
-5,172
Net Income
-37,133
-28,175
-7,346
-5,172
Net Income available to common shareholders
-37,133
-28,175
-7,346
-5,172
Basic EPS
-
-4.80
-1.86
-0.76
Diluted EPS
-
-4.80
-1.86
-0.76
Basic Average Shares
-
5,864
3,942
6,802
Diluted Average Shares
-
5,864
3,942
6,802
EBITDA
-
-27,552
-7,199
-5,147